LiverSource »  Faculty »  Pediatric Hepatology »  Philip Rosenthal, M.D.
Philip Rosenthal, M.D.

Philip Rosenthal, M.D.

Professor of Pediatrics and Surgery
Medical Director, Pediatric Liver Transplant Program
Director, Pediatric Hepatology
 

Contact Information

Academic Office
Room MU 415, Box 0136
University of California, San Francisco
San Francisco, CA 94143-0136
(415) 476-5892
(415) 476-1343 Fax
prosenth@peds.ucsf.edu
Open Popup
  • 1967-71 State Univ. of N.Y. at Albany, Albany, NY, B.S. Magna Cum Laude, Biology
  • 1971-75 State Univ. of N.Y. Downstate Med. Ctr. Brooklyn, NY, M.D. Magna Cum Laude
  • 1975-76 Albert Einstein/Bronx Mun. Hosp., NY, Intern Pediatrics
  • 1976-78 Albert Einstein/Bronx Mun. Hosp., NY, Resident Pediatrics
  • 1978-81 University of California, San Francisco, Fellow Pediatric Gastroenterology
  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Subspeciality in Pediatric Gastroenterology
  • American Board of Pediatrics, Certificate of Added Qualification in Transplant Hepatology
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • UCSF Liver Center
  • Pediatric Liver Transplant Program
  • Pediatric Intestinal Rehabilitation and Transplantation Program
  • Bioartificial liver devices
  • Genetics and immunology of biliary atresia
  • Idiopathic neonatal hepatitis
  • Pediatric Acute Liver Failure (PALF)
  • Quality of life after liver transplants

Philip Rosenthal, M.D. is Professor of Pediatrics and Surgery, Medical Director of the Pediatric Liver Transplant Program. and Director of Pediatric Hepatology at UCSF.  Rosenthal completed his medical training at Downstate Medical Center and the Albert Einstein Medical Center in New York. He then completed a fellowship in pediatric gastroenterology at UCSF. He joined the UCSF faculty in 1995 after serving as Professor of Pediatrics at University of California, Los Angeles (UCLA). 

A  pediatric hepatologist at the UCSF Benioff Children's Hospital, Rosenthal is internationally renowned for the care of children with liver disease, including liver cancer, and  those undergoing liver transplantation. In addition, Rosenthal has and currently serves as Principal Investigator on numerous clinical trials to improve the care of patients with pediatric liver disease.

Rosenthal has won numerous honors for his research including work on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary atresia and the quality of life after liver transplants in children. He is a consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Diseases, Alagille Syndrome Alliance, Studies of Pediatric Liver Transplantation (SPLIT), Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). He is also on editorial boards and a regular reviewer for leading professional journals.

  • Murray Davidson Award, American Academy of Pediatrics, 2013
  • Chancellor's Award for Public Service, UCSF, 2002

Rosenthal is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary disease, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children. 

Clinical Research

Rosenthal is principal investigator on numerous clinical trials including the following:

View all trials 

Most recent publications from a total of 189
  1. Wirth S, Rosenthal P, Gonzalez-Peralta RP, Jonas MM, Balistreri WF, Lin CH, Hardikar W, Kersey K, Massetto B, Kanwar B, Brainard DM, Shao J, Svarovskaia E, Kirby B, Arnon R, Murray KF, Schwarz KB. Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection. Hepatology. 2017 Oct; 66(4):1102-1110. View in PubMed
  2. Smith SK, Rosenthal P. Pediatric liver failure: we came, we saw, but have we conquered? F1000Res. 2017; 6:1540. View in PubMed
  3. Ippolito MM, Johnson J, Mullin C, Mallow C, Morgan N, Wallender E, Li T, Rosenthal PJ. The Relative Effects of Artemether-lumefantrine and Non-artemisinin Antimalarials on Gametocyte Carriage and Transmission of Plasmodium falciparum: A Systematic Review and Meta-analysis. Clin Infect Dis. 2017 Aug 01; 65(3):486-494. View in PubMed
  4. Perito ER, Ajmera V, Bass NM, Rosenthal P, Lavine JE, Schwimmer JB, Yates KP, Diehl AM, Molleston JP, Murray KF, Scheimann A, Gill R, Glidden D, Aouizerat B. Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2017 Sep; 1(7):609-622. View in PubMed
  5. Perito ER, Vase T, Ramachandran R, Phelps A, Jen KY, Lustig RH, Feldstein VA, Rosenthal P. Hepatic steatosis after pediatric liver transplant. Liver Transpl. 2017 Jul; 23(7):957-967. View in PubMed
  6. Wojcicki JM, Rehkopf D, Epel E, Rosenthal P. Shorter Leukocyte Telomere Length in Relation to Presumed Nonalcoholic Fatty Liver Disease in Mexican-American Men in NHANES 1999-2002. Int J Hepatol. 2017; 2017:8435178. View in PubMed
  7. Balistreri WF, Murray KF, Rosenthal P, Bansal S, Lin CH, Kersey K, Massetto B, Zhu Y, Kanwar B, German P, Svarovskaia E, Brainard DM, Wen J, Gonzalez-Peralta RP, Jonas MM, Schwarz K. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection. Hepatology. 2017 Aug; 66(2):371-378. View in PubMed
  8. Shneider BL, Moore J, Kerkar N, Magee JC, Ye W, Karpen SJ, Kamath BM, Molleston JP, Bezerra JA, Murray KF, Loomes KM, Whitington PF, Rosenthal P, Squires RH, Guthery SL, Arnon R, Schwarz KB, Turmelle YP, Sherker AH, Sokol RJ. Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia? PLoS One. 2017; 12(5):e0176275. View in PubMed
  9. Schwarzenberg SJ, Ling SC, Cloonan YK, Lin HS, Evon DM, Murray KF, Rodriguez-Baez N, Rosenthal P, Teckman J, Schwarz KB. Health-related Quality of Life in Pediatric Patients With Chronic Hepatitis B Living in the United States and Canada. J Pediatr Gastroenterol Nutr. 2017 May; 64(5):760-769. View in PubMed
  10. Wang KS, Tiao G, Bass LM, Hertel PM, Mogul D, Kerkar N, Clifton M, Azen C, Bull L, Rosenthal P, Stewart D, Superina R, Arnon R, Bozic M, Brandt ML, Dillon PA, Fecteau A, Iyer K, Kamath B, Karpen S, Karrer F, Loomes KM, Mack C, Mattei P, Miethke A, Soltys K, Turmelle YP, West K, Zagory J, Goodhue C, Shneider BL. Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatology. 2017 May; 65(5):1645-1654. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Philip Rosenthal, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.
  • Alfonso Garcia

    A Young Man Saves Teen's Life

    Alfonso Garcia was just like any other typical healthy and active 16-year-old. He dreamed of attending the U.S. Military Academy at West Point, boxing, and serving in the military like his two other brothers. Then, in January 2010, he suddenly started feeling sick. He became feverish, anemic, fatigued and jaundiced. Alfonso found out that he had Wilson's disease, a rare genetic disorder in which copper in the body isn't properly eliminated and instead accumulates, damaging the liver and nervous system. Alfonso and his family received a grave[...]
    Story Categories: Liver TransplantWilson Disease

X